Roe Organ Preservation Market (2025-2030)
The Roe Organ Preservation Market was valued at $73.03 Million in 2025 and projected to reach to $104.23 Million by 2030, representing a compound annual growth rate of 7.4%. Roe's organ preservation market is positioned for sustained growth through 2030, supported by demographic shifts toward aging populations and rising incidence of organ failure conditions.
Roe Organ Preservation Market Trends and Insights
- Asia Pacific's 7.4% compound annual growth rate outpaces global trends, driven by increasing organ transplant demand, aging populations, and healthcare infrastructure investments across the region.
- Rising prevalence of organ failure and government initiatives to improve transplant accessibility are accelerating adoption of advanced preservation technologies in Asia Pacific. Asia Pacific's market expansion reflects growing clinical recognition of organ preservation solutions in extending viable transplant windows and improving patient outcomes.
- Between 2025 and 2030, Asia Pacific is expected to capture significant market share as countries strengthen transplant networks and regulatory frameworks.
- The region's diverse healthcare landscape—spanning developed economies and emerging markets—creates varied opportunities for preservation technology providers operating in Asia Pacific..
Key Market Statistics
- CAGR (2025-2030) 7.4% CAGR
- Market Size, 2025 ~USD 73.03 Million
- Forecast, 2030 ~USD 104.23 Million
- Country Roe
Roe Organ Preservation Market Overview
Market Valuation :
Roe's organ preservation market is valued at $73.03 million in 2025, demonstrating significant healthcare investment in transplantation infrastructure and preservation technologies across the region.
Accelerated Growth Trajectory :
With a 7.4% CAGR through 2030, Roe is outperforming the global average of 6.8%, indicating stronger regional demand for organ preservation solutions and advanced medical capabilities.
Projected Market Expansion :
The market is forecasted to reach $104.23 million by 2030, representing a 42.8% increase over five years, driven by rising transplant procedures and healthcare modernization initiatives in Roe.
Regional Healthcare Growth Drivers :
Roe's market expansion is fueled by aging populations, increasing organ failure prevalence, government healthcare investments, and enhanced transplant infrastructure development across the region.
Roe Organ Preservation Market Dynamics
- Healthcare infrastructure investments and government initiatives to expand transplantation capabilities are creating favorable conditions for market expansion.
- The region's 7.4% CAGR reflects strong demand for innovative preservation technologies and solutions. Key growth catalysts include increasing organ transplant volumes, adoption of advanced preservation systems, and healthcare modernization efforts.
- Roe's market trajectory suggests growing recognition of organ preservation's critical role in improving transplant outcomes and patient survival rates.
- Strategic investments in medical technology and transplant infrastructure will continue driving market development through the forecast period..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Asia Pacific organ preservation market valued at $73.03M in 2025, expanding to $104.23M by 2030 at 7.4% CAGR
- Asia Pacific growth rate of 7.4% exceeds global average, reflecting strong regional demand for transplant solutions
- Aging demographics and organ failure prevalence in Asia Pacific are primary drivers of preservation technology adoption
- Asia Pacific's diverse healthcare infrastructure creates differentiated market opportunities across developed and emerging economies
Organ Preservation Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PERFADEX (Solution) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.8% from 2025 to 2030 |
| Largest Segment | ORGAN TRANSPLANT CENTERS (End User) |
| Market Size Base Year (Billions) | ~USD 0.22 (2025) |
| Revenue Forecast (Billions) | ~USD 0.3 (2030) |
| Segments Covered | Solution, Technique, Organ Type, End User |
Roe Organ Preservation Market Report Segmentation
4 segment dimensions are covered across the global market.
By Solution
- Custodiol Htk
- Other Solutions
- Perfadex
- University Of Wisconsin Solution
By Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Static Cold Storage
By Organ Type
- Heart
- Kidneys
- Liver
- Lungs
- Other Organs
By End User
- Hospitals
- Organ Transplant Centers
- Specialty Clinics
Target Audience
- Medical Device Manufacturers : Manufacturers of organ preservation systems and technologies need Roe-specific market data to identify growth opportunities, assess market demand, and develop region-tailored product strategies.
- Healthcare Investment Firms : Investment professionals require detailed market sizing and growth forecasts for Roe to evaluate investment opportunities in transplantation infrastructure, medical technology, and healthcare services.
- Hospital & Transplant Center Operators : Healthcare facility administrators need market insights to justify preservation technology investments, benchmark against regional trends, and optimize transplant program capabilities in Roe.
- Pharmaceutical & Biotech Companies : Organizations developing organ preservation solutions and transplant-related therapies require Roe market intelligence to guide R&D investments and commercialization strategies in the region.
- Government & Healthcare Policy Makers : Policy officials and healthcare administrators need market data to inform infrastructure investments, transplant program development, and healthcare resource allocation decisions across Roe.
Key Companies in the Roe Organ Preservation Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Static Cold Storage–linked care (all solutions),Hypothermic machine perfusion–linked care,Normothermic perfusion–linked care, |
| XVIVO PERFUSION AB | Sweden | Public Company | Perfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions, |
| TRANSMEDICS, INC. | United States | Public Company | OCS Heart,OCS Lung,OCS Liver, |
| BIOLIFE SOLUTIONS, INC. | United States | Public Company | HypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport), |
| SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | UW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms), |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.
XVIVO PERFUSION AB
XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.
TRANSMEDICS, INC.
TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.
BIOLIFE SOLUTIONS, INC.
BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise market valuation data for Roe ($73.03M in 2025) and verified forecasts through 2030, enabling accurate business planning and investment decisions in the region's organ preservation sector.
- Competitive Positioning Intelligence : Understand Roe's 7.4% CAGR advantage over global trends (6.8%), identifying market dynamics and competitive opportunities specific to regional healthcare infrastructure and transplant demand patterns.
- Strategic Market Entry Planning : Access detailed insights into Roe's organ preservation landscape to develop targeted market entry strategies, partnership opportunities, and product positioning aligned with regional healthcare priorities.
- Investment & Expansion Justification : Leverage comprehensive market data to justify capital investments, secure funding, and support business expansion decisions in Roe's high-growth organ preservation and transplantation sector.
- Regulatory & Healthcare Trend Analysis : Gain insights into Roe-specific healthcare infrastructure investments, government initiatives, and regulatory environment shaping organ preservation market opportunities and growth trajectories.
Frequently asked questions
What is the current size of the Asia Pacific organ preservation market?
The Asia Pacific organ preservation market is valued at $73.03 million in 2025 and is projected to grow to $104.23 million by 2030.
What is the growth rate for organ preservation in Asia Pacific?
Asia Pacific's organ preservation market is growing at a compound annual growth rate (CAGR) of 7.4% from 2025 to 2030.
What factors are driving growth in the Asia Pacific organ preservation market?
Key drivers in Asia Pacific include aging populations, rising organ failure prevalence, increased transplant demand, healthcare infrastructure investments, and government initiatives to improve transplant accessibility.
How does Asia Pacific's growth compare to global trends?
Asia Pacific's 7.4% CAGR outpaces the global organ preservation market CAGR of 6.8%, indicating stronger regional momentum and market opportunity.
Which countries in Asia Pacific are leading market growth?
Developed economies and emerging markets across Asia Pacific are contributing to growth, with varying adoption rates based on healthcare infrastructure maturity and transplant program development.
RESEARCH METHODOLOGY
The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.
This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.
Primary Research
Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the organ preservation market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach
Data Triangulation
The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.
Market Definition
Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.
Stakeholders
- Association of Organ Procurement Organizations (AOPO)
- American Transplant Congress (ATC)
- United Network for Organ Sharing (UNOS)
- Network & Alliance of Transplant Coordinators (NATCO)
- Consortium for Organ Preservation in Europe (COPE)
- European Society for Organ Transplantation (ESOT)
- Asian Society of Transplantation (AST)
- National Health Service (UK NHS)
- International Registry on Organ Donation and Transplantation (IRODaT)
- Global Observatory on Donation and Transplants (GODT)
- National Institutes of Health (NIH)
- World Health Organization (WHO)
- Organisation for Economic Co-operation and Development (OECD)
- Centers for Disease Control and Prevention (CDC)
- Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
- White Papers, Journals/Magazines, and News Articles
Report Objectives
- To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
- To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering
Get the Full Organ Preservation Market Report
Full forecast, segment splits, and company analysis for all Organ Preservation Market.
- US Organ Preservation Market
- Canada Organ Preservation Market
- Germany Organ Preservation Market
- France Organ Preservation Market
- UK Organ Preservation Market
- Spain Organ Preservation Market
- Italy Organ Preservation Market
- China Organ Preservation Market
- Japan Organ Preservation Market
- India Organ Preservation Market
- Australia Organ Preservation Market
- South Korea Organ Preservation Market
- Brazil Organ Preservation Market
- Mexico Organ Preservation Market
- GCC Countries Organ Preservation Market
- Rest Of Asia Pacific Organ Preservation Market
- Rest Of Europe Organ Preservation Market
- Rest Of Latin America Organ Preservation Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report